TERUMO CORP revenue for the last year amounted to 5.64 B EUR, the most of which — 3.40 B EUR — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 3.34 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought TERUMO CORP 1.71 B EUR, and the year before that — 1.71 B EUR.